Report Cover

Global CAR T-Cell Immunotherapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026


The CAR T-Cell Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global CAR T-Cell Immunotherapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global CAR T-Cell Immunotherapy market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
CAR T-Cell Immunotherapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Monotherapy
    Combination Therapy

Market segment by Application, can be divided into
    Hematologic Malignancies
    Solid Malignancies

Market segment by players, this report covers
    AbbVie
    Celgene
    Kite Pharma
    Oxford BioMedica
    Novartis
    Gilead
    Pfizer
    Cellectis
    Bellicum
    Mustang Bio
    CARsgen Therapeutics
    Xyphos
    Minerva Biotechnologies
    Adaptimmune
    Ziopharm Oncology
    Aurora Biopharma
    Creative Biolabs

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
    1.1 Product Overview and Scope of CAR T-Cell Immunotherapy
    1.2 Classification of CAR T-Cell Immunotherapy by Type
        1.2.1 Overview: Global CAR T-Cell Immunotherapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Type in 2020
        1.2.3 Monotherapy
        1.2.4 Combination Therapy
    1.3 Global CAR T-Cell Immunotherapy Market by Application
        1.3.1 Overview: Global CAR T-Cell Immunotherapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hematologic Malignancies
        1.3.3 Solid Malignancies
    1.4 Global CAR T-Cell Immunotherapy Market Size & Forecast
    1.5 Global CAR T-Cell Immunotherapy Market Size and Forecast by Region
        1.5.1 Global CAR T-Cell Immunotherapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global CAR T-Cell Immunotherapy Market Size by Region, (2016-2021)
        1.5.3 North America CAR T-Cell Immunotherapy Market Size and Prospect (2016-2026)
        1.5.4 Europe CAR T-Cell Immunotherapy Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific CAR T-Cell Immunotherapy Market Size and Prospect (2016-2026)
        1.5.6 South America CAR T-Cell Immunotherapy Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa CAR T-Cell Immunotherapy Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 CAR T-Cell Immunotherapy Market Drivers
        1.6.2 CAR T-Cell Immunotherapy Market Restraints
        1.6.3 CAR T-Cell Immunotherapy Trends Analysis
2 Company Profiles
    2.1 AbbVie
        2.1.1 AbbVie Details
        2.1.2 AbbVie Major Business
        2.1.3 AbbVie CAR T-Cell Immunotherapy Product and Solutions
        2.1.4 AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 AbbVie Recent Developments and Future Plans
    2.2 Celgene
        2.2.1 Celgene Details
        2.2.2 Celgene Major Business
        2.2.3 Celgene CAR T-Cell Immunotherapy Product and Solutions
        2.2.4 Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Celgene Recent Developments and Future Plans
    2.3 Kite Pharma
        2.3.1 Kite Pharma Details
        2.3.2 Kite Pharma Major Business
        2.3.3 Kite Pharma CAR T-Cell Immunotherapy Product and Solutions
        2.3.4 Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Kite Pharma Recent Developments and Future Plans
    2.4 Oxford BioMedica
        2.4.1 Oxford BioMedica Details
        2.4.2 Oxford BioMedica Major Business
        2.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Product and Solutions
        2.4.4 Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Oxford BioMedica Recent Developments and Future Plans
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis CAR T-Cell Immunotherapy Product and Solutions
        2.5.4 Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Novartis Recent Developments and Future Plans
    2.6 Gilead
        2.6.1 Gilead Details
        2.6.2 Gilead Major Business
        2.6.3 Gilead CAR T-Cell Immunotherapy Product and Solutions
        2.6.4 Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Gilead Recent Developments and Future Plans
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer CAR T-Cell Immunotherapy Product and Solutions
        2.7.4 Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Pfizer Recent Developments and Future Plans
    2.8 Cellectis
        2.8.1 Cellectis Details
        2.8.2 Cellectis Major Business
        2.8.3 Cellectis CAR T-Cell Immunotherapy Product and Solutions
        2.8.4 Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Cellectis Recent Developments and Future Plans
    2.9 Bellicum
        2.9.1 Bellicum Details
        2.9.2 Bellicum Major Business
        2.9.3 Bellicum CAR T-Cell Immunotherapy Product and Solutions
        2.9.4 Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Bellicum Recent Developments and Future Plans
    2.10 Mustang Bio 
        2.10.1 Mustang Bio Details
        2.10.2 Mustang Bio Major Business
        2.10.3 Mustang Bio CAR T-Cell Immunotherapy Product and Solutions
        2.10.4 Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Mustang Bio Recent Developments and Future Plans
    2.11 CARsgen Therapeutics
        2.11.1 CARsgen Therapeutics Details
        2.11.2 CARsgen Therapeutics Major Business
        2.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Product and Solutions
        2.11.4 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 CARsgen Therapeutics Recent Developments and Future Plans
    2.12 Xyphos
        2.12.1 Xyphos Details
        2.12.2 Xyphos Major Business
        2.12.3 Xyphos CAR T-Cell Immunotherapy Product and Solutions
        2.12.4 Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Xyphos Recent Developments and Future Plans
    2.13 Minerva Biotechnologies
        2.13.1 Minerva Biotechnologies Details
        2.13.2 Minerva Biotechnologies Major Business
        2.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Product and Solutions
        2.13.4 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Minerva Biotechnologies Recent Developments and Future Plans
    2.14 Adaptimmune
        2.14.1 Adaptimmune Details
        2.14.2 Adaptimmune Major Business
        2.14.3 Adaptimmune CAR T-Cell Immunotherapy Product and Solutions
        2.14.4 Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Adaptimmune Recent Developments and Future Plans
    2.15 Ziopharm Oncology
        2.15.1 Ziopharm Oncology Details
        2.15.2 Ziopharm Oncology Major Business
        2.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Product and Solutions
        2.15.4 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Ziopharm Oncology Recent Developments and Future Plans
    2.16 Aurora Biopharma
        2.16.1 Aurora Biopharma Details
        2.16.2 Aurora Biopharma Major Business
        2.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Product and Solutions
        2.16.4 Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Aurora Biopharma Recent Developments and Future Plans
    2.17 Creative Biolabs
        2.17.1 Creative Biolabs Details
        2.17.2 Creative Biolabs Major Business
        2.17.3 Creative Biolabs CAR T-Cell Immunotherapy Product and Solutions
        2.17.4 Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 Creative Biolabs Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global CAR T-Cell Immunotherapy Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 CAR T-Cell Immunotherapy Players Market Share
        3.2.2 Top 10 CAR T-Cell Immunotherapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 CAR T-Cell Immunotherapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Type (2016-2021)
    4.2 Global CAR T-Cell Immunotherapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)
    5.2 CAR T-Cell Immunotherapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America CAR T-Cell Immunotherapy Revenue by Type (2016-2026)
    6.2 North America CAR T-Cell Immunotherapy Revenue by Application (2016-2026)
    6.3 North America CAR T-Cell Immunotherapy Market Size by Country
        6.3.1 North America CAR T-Cell Immunotherapy Revenue by Country (2016-2026)
        6.3.2 United States CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        6.3.3 Canada CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        6.3.4 Mexico CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe CAR T-Cell Immunotherapy Revenue by Type (2016-2026)
    7.2 Europe CAR T-Cell Immunotherapy Revenue by Application (2016-2026)
    7.3 Europe CAR T-Cell Immunotherapy Market Size by Country
        7.3.1 Europe CAR T-Cell Immunotherapy Revenue by Country (2016-2026)
        7.3.2 Germany CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        7.3.3 France CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        7.3.5 Russia CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        7.3.6 Italy CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Type (2016-2026)
    8.2 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Application (2016-2026)
    8.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region
        8.3.1 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Region (2016-2026)
        8.3.2 China CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        8.3.3 Japan CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        8.3.4 South Korea CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        8.3.5 India CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        8.3.7 Australia CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America CAR T-Cell Immunotherapy Revenue by Type (2016-2026)
    9.2 South America CAR T-Cell Immunotherapy Revenue by Application (2016-2026)
    9.3 South America CAR T-Cell Immunotherapy Market Size by Country
        9.3.1 South America CAR T-Cell Immunotherapy Revenue by Country (2016-2026)
        9.3.2 Brazil CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        9.3.3 Argentina CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa CAR T-Cell Immunotherapy Revenue by Type (2016-2026)
    10.2 Middle East & Africa CAR T-Cell Immunotherapy Revenue by Application (2016-2026)
    10.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country
        10.3.1 Middle East & Africa CAR T-Cell Immunotherapy Revenue by Country (2016-2026)
        10.3.2 Turkey CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
        10.3.4 UAE CAR T-Cell Immunotherapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global CAR T-Cell Immunotherapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global CAR T-Cell Immunotherapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market CAR T-Cell Immunotherapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global CAR T-Cell Immunotherapy Revenue (USD Million) by Region (2016-2021) Table 5. Global CAR T-Cell Immunotherapy Revenue Market Share by Region (2021-2026) Table 6. AbbVie Corporate Information, Head Office, and Major Competitors Table 7. AbbVie Major Business Table 8. AbbVie CAR T-Cell Immunotherapy Product and Solutions Table 9. AbbVie CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Celgene Corporate Information, Head Office, and Major Competitors Table 11. Celgene Major Business Table 12. Celgene CAR T-Cell Immunotherapy Product and Solutions Table 13. Celgene CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. Kite Pharma Corporate Information, Head Office, and Major Competitors Table 15. Kite Pharma Major Business Table 16. Kite Pharma CAR T-Cell Immunotherapy Product and Solutions Table 17. Kite Pharma CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. Oxford BioMedica Corporate Information, Head Office, and Major Competitors Table 19. Oxford BioMedica Major Business Table 20. Oxford BioMedica CAR T-Cell Immunotherapy Product and Solutions Table 21. Oxford BioMedica CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. Novartis Corporate Information, Head Office, and Major Competitors Table 23. Novartis Major Business Table 24. Novartis CAR T-Cell Immunotherapy Product and Solutions Table 25. Novartis CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. Gilead Corporate Information, Head Office, and Major Competitors Table 27. Gilead Major Business Table 28. Gilead CAR T-Cell Immunotherapy Product and Solutions Table 29. Gilead CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. Pfizer Corporate Information, Head Office, and Major Competitors Table 31. Pfizer Major Business Table 32. Pfizer CAR T-Cell Immunotherapy Product and Solutions Table 33. Pfizer CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. Cellectis Corporate Information, Head Office, and Major Competitors Table 35. Cellectis Major Business Table 36. Cellectis CAR T-Cell Immunotherapy Product and Solutions Table 37. Cellectis CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. Bellicum Corporate Information, Head Office, and Major Competitors Table 39. Bellicum Major Business Table 40. Bellicum CAR T-Cell Immunotherapy Product and Solutions Table 41. Bellicum CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 42. Mustang Bio Corporate Information, Head Office, and Major Competitors Table 43. Mustang Bio Major Business Table 44. Mustang Bio CAR T-Cell Immunotherapy Product and Solutions Table 45. Mustang Bio CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 46. CARsgen Therapeutics Corporate Information, Head Office, and Major Competitors Table 47. CARsgen Therapeutics Major Business Table 48. CARsgen Therapeutics CAR T-Cell Immunotherapy Product and Solutions Table 49. CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 50. Xyphos Corporate Information, Head Office, and Major Competitors Table 51. Xyphos Major Business Table 52. Xyphos CAR T-Cell Immunotherapy Product and Solutions Table 53. Xyphos CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 54. Minerva Biotechnologies Corporate Information, Head Office, and Major Competitors Table 55. Minerva Biotechnologies Major Business Table 56. Minerva Biotechnologies CAR T-Cell Immunotherapy Product and Solutions Table 57. Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 58. Adaptimmune Corporate Information, Head Office, and Major Competitors Table 59. Adaptimmune Major Business Table 60. Adaptimmune CAR T-Cell Immunotherapy Product and Solutions Table 61. Adaptimmune CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 62. Ziopharm Oncology Corporate Information, Head Office, and Major Competitors Table 63. Ziopharm Oncology Major Business Table 64. Ziopharm Oncology CAR T-Cell Immunotherapy Product and Solutions Table 65. Ziopharm Oncology CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 66. Aurora Biopharma Corporate Information, Head Office, and Major Competitors Table 67. Aurora Biopharma Major Business Table 68. Aurora Biopharma CAR T-Cell Immunotherapy Product and Solutions Table 69. Aurora Biopharma CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 70. Creative Biolabs Corporate Information, Head Office, and Major Competitors Table 71. Creative Biolabs Major Business Table 72. Creative Biolabs CAR T-Cell Immunotherapy Product and Solutions Table 73. Creative Biolabs CAR T-Cell Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 74. Global CAR T-Cell Immunotherapy Revenue (USD Million) by Players (2019-2021) Table 75. Global CAR T-Cell Immunotherapy Revenue Share by Players (2019-2021) Table 76. Breakdown of CAR T-Cell Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3) Table 77. CAR T-Cell Immunotherapy Players Head Office, Products and Services Provided Table 78. CAR T-Cell Immunotherapy Mergers & Acquisitions in the Past Five Years Table 79. CAR T-Cell Immunotherapy New Entrants and Expansion Plans Table 80. Global CAR T-Cell Immunotherapy Revenue (USD Million) by Type (2016-2021) Table 81. Global CAR T-Cell Immunotherapy Revenue Share by Type (2016-2021) Table 82. Global CAR T-Cell Immunotherapy Revenue Forecast by Type (2021-2026) Table 83. Global CAR T-Cell Immunotherapy Revenue by Application (2016-2021) Table 84. Global CAR T-Cell Immunotherapy Revenue Forecast by Application (2021-2026) Table 85. North America CAR T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million) Table 86. North America CAR T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million) Table 87. North America CAR T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million) Table 88. North America CAR T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million) Table 89. North America CAR T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million) Table 90. North America CAR T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million) Table 91. Europe CAR T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million) Table 92. Europe CAR T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million) Table 93. Europe CAR T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million) Table 94. Europe CAR T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million) Table 95. Europe CAR T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million) Table 96. Europe CAR T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million) Table 97. Asia-Pacific CAR T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million) Table 98. Asia-Pacific CAR T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million) Table 99. Asia-Pacific CAR T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million) Table 100. Asia-Pacific CAR T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million) Table 101. Asia-Pacific CAR T-Cell Immunotherapy Revenue by Region (2016-2021) & (USD Million) Table 102. Asia-Pacific CAR T-Cell Immunotherapy Revenue by Region (2021-2026) & (USD Million) Table 103. South America CAR T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million) Table 104. South America CAR T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million) Table 105. South America CAR T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million) Table 106. South America CAR T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million) Table 107. South America CAR T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million) Table 108. South America CAR T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million) Table 109. Middle East & Africa CAR T-Cell Immunotherapy Revenue by Type (2016-2021) & (USD Million) Table 110. Middle East & Africa CAR T-Cell Immunotherapy Revenue by Type (2021-2026) & (USD Million) Table 111. Middle East & Africa CAR T-Cell Immunotherapy Revenue by Application (2016-2021) & (USD Million) Table 112. Middle East & Africa CAR T-Cell Immunotherapy Revenue by Application (2021-2026) & (USD Million) Table 113. Middle East & Africa CAR T-Cell Immunotherapy Revenue by Country (2016-2021) & (USD Million) Table 114. Middle East & Africa CAR T-Cell Immunotherapy Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. CAR T-Cell Immunotherapy Picture Figure 2. Global CAR T-Cell Immunotherapy Revenue Market Share by Type in 2020 Figure 3. Monotherapy Figure 4. Combination Therapy Figure 5. CAR T-Cell Immunotherapy Revenue Market Share by Application in 2020 Figure 6. Hematologic Malignancies Picture Figure 7. Solid Malignancies Picture Figure 8. Global CAR T-Cell Immunotherapy Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 9. Global CAR T-Cell Immunotherapy Revenue and Forecast (2016-2026) & (USD Million) Figure 10. Global CAR T-Cell Immunotherapy Revenue Market Share by Region (2016-2026) Figure 11. Global CAR T-Cell Immunotherapy Revenue Market Share by Region in 2020 Figure 12. North America CAR T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026) Figure 13. Europe CAR T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026) Figure 14. Asia-Pacific CAR T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026) Figure 15. South America CAR T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026) Figure 16. Middle East and Africa CAR T-Cell Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026) Figure 17. CAR T-Cell Immunotherapy Market Drivers Figure 18. CAR T-Cell Immunotherapy Market Restraints Figure 19. CAR T-Cell Immunotherapy Market Trends Figure 20. AbbVie Recent Developments and Future Plans Figure 21. Celgene Recent Developments and Future Plans Figure 22. Kite Pharma Recent Developments and Future Plans Figure 23. Oxford BioMedica Recent Developments and Future Plans Figure 24. Novartis Recent Developments and Future Plans Figure 25. Gilead Recent Developments and Future Plans Figure 26. Pfizer Recent Developments and Future Plans Figure 27. Cellectis Recent Developments and Future Plans Figure 28. Bellicum Recent Developments and Future Plans Figure 29. Mustang Bio Recent Developments and Future Plans Figure 30. CARsgen Therapeutics Recent Developments and Future Plans Figure 31. Xyphos Recent Developments and Future Plans Figure 32. Minerva Biotechnologies Recent Developments and Future Plans Figure 33. Adaptimmune Recent Developments and Future Plans Figure 34. Ziopharm Oncology Recent Developments and Future Plans Figure 35. Aurora Biopharma Recent Developments and Future Plans Figure 36. Creative Biolabs Recent Developments and Future Plans Figure 37. Global CAR T-Cell Immunotherapy Revenue Share by Players in 2020 Figure 38. CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 39. Global Top 3 Players CAR T-Cell Immunotherapy Revenue Market Share in 2020 Figure 40. Global Top 10 Players CAR T-Cell Immunotherapy Revenue Market Share in 2020 Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 42. Global CAR T-Cell Immunotherapy Revenue Share by Type in 2020 Figure 43. Global CAR T-Cell Immunotherapy Market Share Forecast by Type (2021-2026) Figure 44. Global CAR T-Cell Immunotherapy Revenue Share by Application in 2020 Figure 45. Global CAR T-Cell Immunotherapy Market Share Forecast by Application (2021-2026) Figure 46. North America CAR T-Cell Immunotherapy Sales Market Share by Type (2016-2026) Figure 47. North America CAR T-Cell Immunotherapy Sales Market Share by Application (2016-2026) Figure 48. North America CAR T-Cell Immunotherapy Revenue Market Share by Country (2016-2026) Figure 49. United States CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 50. Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 51. Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 52. Europe CAR T-Cell Immunotherapy Sales Market Share by Type (2016-2026) Figure 53. Europe CAR T-Cell Immunotherapy Sales Market Share by Application (2016-2026) Figure 54. Europe CAR T-Cell Immunotherapy Revenue Market Share by Country (2016-2026) Figure 55. Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 56. France CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 57. United Kingdom CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 58. Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 59. Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 60. Asia-Pacific CAR T-Cell Immunotherapy Sales Market Share by Type (2016-2026) Figure 61. Asia-Pacific CAR T-Cell Immunotherapy Sales Market Share by Application (2016-2026) Figure 62. Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Region (2016-2026) Figure 63. China CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 64. Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 65. South Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 66. India CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 67. Southeast Asia CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 68. Australia CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 69. South America CAR T-Cell Immunotherapy Sales Market Share by Type (2016-2026) Figure 70. South America CAR T-Cell Immunotherapy Sales Market Share by Application (2016-2026) Figure 71. South America CAR T-Cell Immunotherapy Revenue Market Share by Country (2016-2026) Figure 72. Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 73. Argentina CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 74. Middle East and Africa CAR T-Cell Immunotherapy Sales Market Share by Type (2016-2026) Figure 75. Middle East and Africa CAR T-Cell Immunotherapy Sales Market Share by Application (2016-2026) Figure 76. Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Country (2016-2026) Figure 77. Turkey CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 78. Saudi Arabia CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 79. UAE CAR T-Cell Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million) Figure 80. Methodology Figure 81. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us